Accelerate Diagnostics, Inc. (AXDX)
USD 0.64
(-7.51%)
USD 0.64
(-7.51%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 51.25 Million USD | -41.28% |
| 2022 | 87.27 Million USD | -26.11% |
| 2021 | 118.11 Million USD | -24.4% |
| 2020 | 156.23 Million USD | 10.18% |
| 2019 | 141.8 Million USD | 10.88% |
| 2018 | 127.89 Million USD | 1778.8% |
| 2017 | 6.8 Million USD | 35.17% |
| 2016 | 5.03 Million USD | -20.14% |
| 2015 | 6.3 Million USD | 65.51% |
| 2014 | 3.81 Million USD | 99.1% |
| 2013 | 1.91 Million USD | -19.54% |
| 2012 | 2.37 Million USD | 64.14% |
| 2011 | 1.44 Million USD | 6.6% |
| 2010 | 1.35 Million USD | 1.66% |
| 2009 | 1.33 Million USD | -5.48% |
| 2008 | 1.41 Million USD | 12.45% |
| 2007 | 1.25 Million USD | 13.43% |
| 2006 | 1.1 Million USD | -17.23% |
| 2005 | 1.33 Million USD | 35.59% |
| 2004 | 988.09 Thousand USD | -2.77% |
| 2003 | 1.01 Million USD | -20.56% |
| 2002 | 1.27 Million USD | 14.19% |
| 2001 | 1.12 Million USD | -39.23% |
| 2000 | 1.84 Million USD | 0.38% |
| 1999 | 1.83 Million USD | 13.45% |
| 1998 | 1.61 Million USD | 169.81% |
| 1997 | 600 Thousand USD | 50.0% |
| 1996 | 400 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 57.75 Million USD | 2.22% |
| 2024 Q1 | 56.5 Million USD | 10.24% |
| 2023 FY | 51.25 Million USD | -41.28% |
| 2023 Q1 | 89.72 Million USD | 2.8% |
| 2023 Q2 | 88.54 Million USD | -1.32% |
| 2023 Q4 | 51.25 Million USD | -31.07% |
| 2023 Q3 | 74.35 Million USD | -16.02% |
| 2022 Q1 | 127.13 Million USD | 7.63% |
| 2022 FY | 87.27 Million USD | -26.11% |
| 2022 Q4 | 87.27 Million USD | 1.91% |
| 2022 Q3 | 85.64 Million USD | -29.04% |
| 2022 Q2 | 120.69 Million USD | -5.07% |
| 2021 Q3 | 120.9 Million USD | -26.16% |
| 2021 Q4 | 118.11 Million USD | -2.31% |
| 2021 FY | 118.11 Million USD | -24.4% |
| 2021 Q1 | 159.03 Million USD | 1.79% |
| 2021 Q2 | 163.73 Million USD | 2.96% |
| 2020 Q3 | 153.88 Million USD | 1.37% |
| 2020 Q4 | 156.23 Million USD | 1.53% |
| 2020 Q1 | 142.93 Million USD | 0.8% |
| 2020 FY | 156.23 Million USD | 10.18% |
| 2020 Q2 | 151.8 Million USD | 6.21% |
| 2019 Q2 | 132.63 Million USD | 2.65% |
| 2019 Q3 | 137.05 Million USD | 3.33% |
| 2019 FY | 141.8 Million USD | 10.88% |
| 2019 Q4 | 141.8 Million USD | 3.46% |
| 2019 Q1 | 129.21 Million USD | 1.04% |
| 2018 Q1 | 106.64 Million USD | 1466.39% |
| 2018 FY | 127.89 Million USD | 1778.8% |
| 2018 Q4 | 127.89 Million USD | 3.76% |
| 2018 Q3 | 123.25 Million USD | -0.09% |
| 2018 Q2 | 123.36 Million USD | 15.69% |
| 2017 Q1 | 5.27 Million USD | 4.67% |
| 2017 Q3 | 6.18 Million USD | -0.64% |
| 2017 Q4 | 6.8 Million USD | 10.11% |
| 2017 FY | 6.8 Million USD | 35.17% |
| 2017 Q2 | 6.22 Million USD | 18.06% |
| 2016 Q2 | 5.47 Million USD | -8.57% |
| 2016 Q4 | 5.03 Million USD | -7.58% |
| 2016 Q3 | 5.44 Million USD | -0.46% |
| 2016 FY | 5.03 Million USD | -20.14% |
| 2016 Q1 | 5.98 Million USD | -5.06% |
| 2015 Q2 | 3.99 Million USD | -11.47% |
| 2015 Q1 | 4.51 Million USD | 18.5% |
| 2015 Q4 | 6.3 Million USD | 38.05% |
| 2015 FY | 6.3 Million USD | 65.51% |
| 2015 Q3 | 4.56 Million USD | 14.29% |
| 2014 FY | 3.81 Million USD | 99.1% |
| 2014 Q1 | 2.6 Million USD | 36.29% |
| 2014 Q3 | 2.87 Million USD | -7.23% |
| 2014 Q4 | 3.81 Million USD | 32.48% |
| 2014 Q2 | 3.1 Million USD | 18.87% |
| 2013 Q2 | 1.8 Million USD | 59.08% |
| 2013 Q3 | 938.6 Thousand USD | -48.06% |
| 2013 Q4 | 1.91 Million USD | 103.88% |
| 2013 FY | 1.91 Million USD | -19.54% |
| 2013 Q1 | 1.13 Million USD | -8.98% |
| 2012 Q1 | 1.65 Million USD | -0.31% |
| 2012 Q2 | 2.37 Million USD | 43.45% |
| 2012 Q3 | 2.42 Million USD | 1.97% |
| 2012 Q4 | 1.24 Million USD | -48.54% |
| 2012 FY | 2.37 Million USD | 64.14% |
| 2011 Q2 | 1.44 Million USD | -4.28% |
| 2011 FY | 1.44 Million USD | 6.6% |
| 2011 Q1 | 1.51 Million USD | 2.69% |
| 2011 Q3 | 1.59 Million USD | 10.01% |
| 2011 Q4 | 1.66 Million USD | 4.34% |
| 2010 Q1 | 1.41 Million USD | 3.0% |
| 2010 FY | 1.35 Million USD | 1.66% |
| 2010 Q4 | 1.47 Million USD | 2.94% |
| 2010 Q3 | 1.43 Million USD | 5.36% |
| 2010 Q2 | 1.35 Million USD | -3.74% |
| 2009 Q3 | 1.36 Million USD | 1.77% |
| 2009 FY | 1.33 Million USD | -5.48% |
| 2009 Q1 | 1.39 Million USD | 7.1% |
| 2009 Q2 | 1.33 Million USD | -4.49% |
| 2009 Q4 | 1.37 Million USD | 0.76% |
| 2008 Q4 | 1.3 Million USD | -1.16% |
| 2008 Q3 | 1.32 Million USD | -6.52% |
| 2008 Q1 | 1.37 Million USD | -7.15% |
| 2008 Q2 | 1.41 Million USD | 2.92% |
| 2008 FY | 1.41 Million USD | 12.45% |
| 2007 Q4 | 1.48 Million USD | 4.57% |
| 2007 Q2 | 1.25 Million USD | -1.33% |
| 2007 Q3 | 1.41 Million USD | 12.52% |
| 2007 Q1 | 1.27 Million USD | 1.22% |
| 2007 FY | 1.25 Million USD | 13.43% |
| 2006 Q4 | 1.25 Million USD | 6.58% |
| 2006 FY | 1.1 Million USD | -17.23% |
| 2006 Q3 | 1.18 Million USD | 6.57% |
| 2006 Q2 | 1.1 Million USD | -8.41% |
| 2006 Q1 | 1.21 Million USD | 4.32% |
| 2005 Q3 | 1.17 Million USD | -11.92% |
| 2005 Q4 | 1.16 Million USD | -1.64% |
| 2005 Q1 | 1.03 Million USD | 1.79% |
| 2005 FY | 1.33 Million USD | 35.59% |
| 2005 Q2 | 1.33 Million USD | 29.83% |
| 2004 Q1 | 1.13 Million USD | 4.06% |
| 2004 FY | 988.09 Thousand USD | -2.77% |
| 2004 Q4 | 1.01 Million USD | -0.91% |
| 2004 Q2 | 988.09 Thousand USD | -13.1% |
| 2004 Q3 | 1.02 Million USD | 3.54% |
| 2003 Q4 | 1.09 Million USD | 10.66% |
| 2003 FY | 1.01 Million USD | -20.56% |
| 2003 Q3 | 987.42 Thousand USD | -2.83% |
| 2003 Q2 | 1.01 Million USD | 11.6% |
| 2003 Q1 | 910.56 Thousand USD | -33.2% |
| 2002 Q4 | 1.36 Million USD | 2.26% |
| 2002 FY | 1.27 Million USD | 14.19% |
| 2002 Q1 | 820.93 Thousand USD | -3.84% |
| 2002 Q2 | 1.27 Million USD | 55.83% |
| 2002 Q3 | 1.33 Million USD | 4.2% |
| 2001 Q2 | 1.12 Million USD | -1.08% |
| 2001 Q4 | 853.73 Thousand USD | -5.33% |
| 2001 FY | 1.12 Million USD | -39.23% |
| 2001 Q3 | 901.77 Thousand USD | -19.51% |
| 2001 Q1 | 1.13 Million USD | -16.8% |
| 2000 FY | 1.84 Million USD | 0.38% |
| 2000 Q4 | 1.36 Million USD | -21.4% |
| 2000 Q3 | 1.73 Million USD | -6.06% |
| 2000 Q2 | 1.84 Million USD | 6.86% |
| 2000 Q1 | 1.72 Million USD | -18.23% |
| 1999 FY | 1.83 Million USD | 13.45% |
| 1999 Q1 | 1.83 Million USD | 29.39% |
| 1999 Q2 | 1.83 Million USD | -0.04% |
| 1999 Q3 | 1.84 Million USD | 0.22% |
| 1999 Q4 | 2.1 Million USD | 14.62% |
| 1998 Q2 | 1.61 Million USD | -25.47% |
| 1998 Q1 | 2.17 Million USD | 42.75% |
| 1998 Q3 | 1.39 Million USD | -13.65% |
| 1998 Q4 | 1.41 Million USD | 1.57% |
| 1998 FY | 1.61 Million USD | 169.81% |
| 1997 Q3 | 1.4 Million USD | 134.73% |
| 1997 Q2 | 600 Thousand USD | 100.0% |
| 1997 Q1 | 300 Thousand USD | -25.0% |
| 1997 FY | 600 Thousand USD | 50.0% |
| 1997 Q4 | 1.52 Million USD | 8.04% |
| 1996 Q4 | 400 Thousand USD | -20.0% |
| 1996 Q1 | 200 Thousand USD | 0.0% |
| 1996 FY | 400 Thousand USD | 0.0% |
| 1996 Q2 | 400 Thousand USD | 100.0% |
| 1996 Q3 | 500 Thousand USD | 25.0% |
| 1995 Q4 | 200 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| BrainsWay Ltd. | 15.31 Million USD | -234.687% |
| Cerus Corporation | 144.3 Million USD | 64.482% |
| Envoy Medical, Inc. | 9.4 Million USD | -445.139% |
| electroCore, Inc. | 8.94 Million USD | -472.99% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -859.453% |
| IceCure Medical Ltd | 4.24 Million USD | -1106.828% |
| Inogen, Inc. | 121.38 Million USD | 57.775% |
| OrthoPediatrics Corp. | 72.56 Million USD | 29.364% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -73.267% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1510.777% |
| MaxCyte, Inc. | 36.1 Million USD | -41.95% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -2673.62% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -11951.796% |
| Orthofix Medical Inc. | 326.58 Million USD | 84.306% |
| PAVmed Inc | 57.13 Million USD | 10.296% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -101.288% |
| RxSight, Inc. | 22.18 Million USD | -130.999% |
| Sight Sciences, Inc. | 46.43 Million USD | -10.376% |
| SI-BONE, Inc. | 61.05 Million USD | 16.046% |
| TELA Bio, Inc. | 59.16 Million USD | 13.374% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 55.028% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -396.695% |
| Acutus Medical, Inc. | 54.83 Million USD | 6.537% |
| Talis Biomedical Corporation | 29.22 Million USD | -75.383% |
| Spectral AI, Inc. | 12.4 Million USD | -313.305% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -121.553% |
| CVRx, Inc. | 39.28 Million USD | -30.477% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -328.614% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -2009.826% |
| Bioventus Inc. | 589.79 Million USD | 91.31% |
| Venus Concept Inc. | 107.1 Million USD | 52.145% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 0.792% |
| LivaNova PLC | 1.15 Billion USD | 95.551% |
| 908 Devices Inc. | 37.49 Million USD | -36.714% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 92.714% |
| Nemaura Medical Inc. | 26.37 Million USD | -94.31% |
| NeuroPace, Inc. | 86.99 Million USD | 41.085% |
| LENSAR, Inc. | 22.4 Million USD | -128.721% |
| Apyx Medical Corporation | 52.31 Million USD | 2.034% |
| Cutera, Inc. | 518.12 Million USD | 90.108% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -74.761% |
| BioSig Technologies, Inc. | 4.68 Million USD | -994.002% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 12.187% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -138.524% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 97.664% |
| Axonics, Inc. | 82.35 Million USD | 37.768% |
| Outset Medical, Inc. | 190.91 Million USD | 73.153% |
| IRIDEX Corporation | 24.91 Million USD | -105.724% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 58.654% |
| IRadimed Corporation | 20.73 Million USD | -147.175% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -2961.768% |
| INVO Bioscience, Inc. | 19.99 Million USD | -156.335% |
| Telesis Bio, Inc. | 40.87 Million USD | -25.398% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -25.653% |
| Varex Imaging Corporation | 668.6 Million USD | 92.334% |
| Quipt Home Medical Corp. | 136.29 Million USD | 62.394% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1334.882% |
| Pulmonx Corporation | 60.63 Million USD | 15.473% |
| Dynatronics Corporation | 11.78 Million USD | -335.089% |
| Modular Medical, Inc. | 2.27 Million USD | -2155.898% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -1161.171% |
| Semler Scientific, Inc. | 6.27 Million USD | -717.448% |
| InMode Ltd. | 75.91 Million USD | 32.484% |
| Bruker Corporation | 2.83 Billion USD | 98.193% |
| Cytosorbents Corporation | 29.98 Million USD | -70.929% |
| DexCom, Inc. | 4.19 Billion USD | 98.778% |
| Align Technology, Inc. | 2.45 Billion USD | 97.911% |
| Viveve Medical, Inc. | 10.84 Million USD | -372.518% |
| ZimVie Inc. | 795.85 Million USD | 93.56% |
| Movano Inc. | 5.97 Million USD | -758.238% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 51.002% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -11951.796% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -328.614% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 91.979% |
| Profound Medical Corp. | 12.66 Million USD | -304.662% |
| Insulet Corporation | 1.85 Billion USD | 97.238% |
| enVVeno Medical Corporation | 2.43 Million USD | -2004.887% |
| Surmodics, Inc. | 65.82 Million USD | 22.134% |
| iCAD, Inc. | 8 Million USD | -540.595% |
| Nuwellis, Inc. | 6.78 Million USD | -655.959% |
| Biotricity, Inc. | 35.91 Million USD | -42.692% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 77.021% |
| Aethlon Medical, Inc. | 2.47 Million USD | -1966.985% |
| InspireMD, Inc. | 8.14 Million USD | -529.501% |
| PAVmed Inc. | 57.13 Million USD | 10.296% |
| BIOLASE, Inc. | 35.34 Million USD | -44.998% |
| Beyond Air, Inc. | 29.77 Million USD | -72.138% |
| FONAR Corporation | 57.45 Million USD | 10.797% |
| AxoGen, Inc. | 101.16 Million USD | 49.335% |
| Vivani Medical, Inc. | 25.03 Million USD | -104.721% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 41.621% |
| Inari Medical, Inc. | 209.32 Million USD | 75.515% |
| UFP Technologies, Inc. | 118.04 Million USD | 56.581% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -303.877% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -2244.849% |
| Tenon Medical, Inc. | 5.56 Million USD | -820.675% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -2781.057% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -190.653% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.375% |
| Sintx Technologies, Inc. | 6.59 Million USD | -677.4% |
| NanoVibronix, Inc. | 2.68 Million USD | -1808.191% |
| Quanterix Corporation | 78.08 Million USD | 34.36% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1334.882% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -949.212% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 95.094% |
| TransMedics Group, Inc. | 568.84 Million USD | 90.99% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -207.241% |
| NeuroMetrix, Inc. | 1.33 Million USD | -3744.654% |
| Hyperfine, Inc. | 9.8 Million USD | -423.0% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 79.519% |
| Biomerica, Inc. | 2.66 Million USD | -1824.671% |
| Bone Biologics Corporation | 831.4 Thousand USD | -6064.767% |
| AVITA Medical, Inc. | 19.86 Million USD | -158.006% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -2496.871% |
| Silk Road Medical, Inc | 114.15 Million USD | 55.103% |